A  A  A   Print
The Genetics of Prostate Cancer

The Genetics of Prostate Cancer

According to the National Cancer Institute, one in six men will be diagnosed with prostate cancer in their lifetime. The risk is even higher in African-American men.

The majority of cases of prostate cancer are sporadic, which means that one person in the family developed prostate cancer by chance at a typical age of onset.

About 15 percent of prostate cancers are familial, which means there is a father or brother also affected, at typical ages of onset. Familial cancers may be due to a combination of genes and shared lifestyle factors or environmental exposures (multifactorial inheritance). On the other hand, some of these histories can represent a chance occurrence of sporadic cancers. A familial history may also arise due to a single gene mutation (hereditary cancer) that has reduced penetrance (a mutation associated with lower cancer risks and later onset of cancer). In general, with familial cancer, close relatives have a modestly increased risk of developing the cancer in question. The chance that genetic testing will be beneficial in further assessing cancer risks is usually small. Studies have found a trend of an increased chance to develop prostate cancer, with an increasing number of family members. In other words, the more relatives you have with prostate cancer, the higher the risk. Which relatives are affected also influences risk:

Relatives with prostate cancer

Prostate cancer risk

Father diagnosed with prostate cancer at any age

2 to 3 times higher (than the average population risk)

Brother diagnosed with prostate cancer at any age

3 to 4 times higher (than the average population risk)

Two or more first-degree relatives (father, brother, or son) diagnosed at any age

5 times higher (than the average population risk)

One second-degree relative (uncle, grandfather) diagnosed at any age

1.5 to 2 times higher (than the average population risk)

Approximately 5 percent of all prostate cancers can be attributed to a cancer susceptibility gene that is inherited as a dominant trait (from parent to child). Genetic heterogeneity has been observed with prostate cancer, which means that more than one gene has been implicated in its cause. At present, there are many continuing research studies to determine the specific mechanism of how gene mutations contribute to an increased susceptibility for prostate cancer; clinical testing is not available at this time.

 

The third-party content provided in the Health Library of phoebeputney.com is for informational purposes only and is not designed to diagnose or treat a health problem or disease, or replace the professional medical advice you receive from your physician. If you or your child has or suspect you may have a health problem, please consult your primary care physician. If you or your child may have a medical emergency, call your doctor or 911 or other emergency health care provider immediately in the United States or the appropriate health agency of your country. For more information regarding site usage, please visit: Privacy Information, Terms of Use or Disclaimer.

Follow us online:

© 2014 Phoebe Putney Health System  |  417 Third Avenue, Albany, Georgia 31701  |  Telephone 877.312.1167

Phoebe Putney Health System is a network of hospitals, family medicine clinics, rehab facilities, auxiliary services, and medical education training facilities. Founded in 1911,
Phoebe Putney Memorial Hospital (the flagship hospital) is one of Georgia's largest comprehensive regional medical centers. From the beginning, Phoebe's mission and vision
has been to bring the finest medical talent and technology to the citizens of Southwest Georgia, and to serve all citizens of the community regardless of ability to pay.